|
市場調査レポート
商品コード
1126377
慢性疾患管理の世界市場の規模、シェア、産業動向分析レポート:タイプ別(ソリューションとサービス)、エンドユーザー別(ヘルスケアプロバイダー、ヘルスケアペイヤー、その他)、疾患タイプ別、地域別展望と予測、2022年~2028年Global Chronic Disease Management Market Size, Share & Industry Trends Analysis Report By Type (Solutions and Services), By End User (Healthcare Providers, Healthcare Payers and Others), By Disease Type, By Regional Outlook and Forecast, 2022 - 2028 |
||||||
慢性疾患管理の世界市場の規模、シェア、産業動向分析レポート:タイプ別(ソリューションとサービス)、エンドユーザー別(ヘルスケアプロバイダー、ヘルスケアペイヤー、その他)、疾患タイプ別、地域別展望と予測、2022年~2028年 |
出版日: 2022年08月31日
発行: KBV Research
ページ情報: 英文 232 Pages
納期: 即納可能
|
慢性疾患管理の世界市場規模は、予測期間中にCAGR11.7%で上昇し、2028年には99億米ドルに達すると予測されます。
高齢者人口の増加や、癌など数多くの慢性疾患の有病率の上昇が、慢性疾患管理市場拡大の主な要因となっています。例えば、NCBIによると、全世界の全疾患の43パーセントと死亡の60パーセントが慢性疾患によって引き起こされていると言われています。さらに、WHOによると、非伝染性疾患はあらゆる年齢、地理的地域、国の人々に影響を与えています(NCDs)。
さらに、慢性疾患管理市場の成長は、ITソリューションの導入による慢性疾患管理への受容の高まりによってもたらされます。人々が効果的に病気を管理できるようにするため、ヘルスケア専門家、組織、支払者によってさまざまな取り組みが行われています。従来の患者教育とは異なり、問題解決や社会的対処に重点を置き、ケアマネジメントにおける自己効力感を高めるための取り組みが行われています。
COVID-19インパクト分析
慢性疾患管理市場は、COVID-19の全体的な効果による恩恵を受け続けています。COVID-19の発生率の上昇により、多くの国で正確な診断・治療ツールの必要性が高まっています。医療機関は、患者管理、EHR、ケアマネジメントなどのソリューションと、請求管理および支払い管理などの医療費支払者ソリューションを簡単に接続できるため、この点で非常に有益であることが示されています。さらに、この病気の世界の広がりは、閉鎖やその他の制限につながり、電子データ転送と請求管理への需要を高めています。今後数年間で、慢性疾患管理の普及が進むと予想されます。
市場成長要因
各種慢性疾患の患者数増加
予測期間中、糖尿病、癌、高血圧などの慢性疾患の発生率が増加し、市場の成長率を押し上げると考えられます。高齢者は肥満や糖尿病になりやすいことから、慢性疾患は高齢者にとって大きな悩みの種となっています。慢性疾患の治療を受けている多くの患者は、社会経済的な障害に直面しており、日常的にヘルスケア治療を受け、支払いを行うことが困難な状況にあります。このような患者さんは、必要な資金がない場合、必要な治療を延期したり、見合わせたりすることがあります。
増え続ける老年人口
平均寿命が延びたことにより、60代以上の高齢者は確実に増えています。国連の「2020年世界人口高齢化データベース」によると、2020年の7億2,700万人から2050年には世界で15億人の高齢者が生まれるとされています。高齢者では慢性疾患を発症する危険性が高く、慢性疾患管理市場の需要を押し上げる要因となっています。高齢者はさまざまな病気、特に慢性疾患にかかりやすいため、企業は市場での先進的かつ改良されたソリューションの導入を主な目的としています。
市場抑制要因
慢性期医療における適切なコミュニケーションの欠如
質の高い患者ケアを提供できるかどうかは、効果的なコミュニケーションにかかっており、これは医療提供者と患者の相互作用の基礎でもあります。患者が理解され、話を聞いてもらえたと感じることで、医療従事者はより適切な治療を提供することができるようになります。また、診察が終わった後も、同じ患者さんが、推奨された治療方針に従おうとする傾向があります。パンデミックは、患者さんの期待や行動に大きな変化をもたらしました。
疾患タイプ別展望
慢性疾患管理市場は、疾患の種類によって、心血管疾患、糖尿病、がん、喘息、慢性閉塞性肺疾患、その他に分類されます。がん分野は、2021年の慢性疾患管理市場において有望な収益シェアを示しました。それは、個人の間で様々なタイプの癌の症例が増加していることに起因しています。一般的に、がんの種類は、最初に出現した臓器や組織の名前で呼ばれています。
タイプ別展望
慢性疾患管理市場は、タイプ別にソリューションとサービスに分類されます。2021年の慢性疾患管理市場では、ソリューション部門が最も高い収益シェアを獲得しました。慢性疾患管理システムおよび市場の拡大は、ヘルスケアにおけるクラウド型およびオンプレミス型ソリューションの活用に対する意識の高まりが要因です。
エンドユーザー別の展望
エンドユーザー別では、慢性疾患管理市場は、ヘルスケアプロバイダ、ヘルスケアペイヤー、その他に分類されます。ヘルスケアペイヤー部門は、2021年の慢性疾患管理市場で大きな収益シェアを調達しました。老年人口の増加や慢性疾患の発生により、市場が拡大しています。サービス価格の決定、請求の処理、支払いの回収、プロバイダーへの支払いなどを行う組織には、メディケア、ヘルスプランプロバイダ、メディケイドなどの医療分野の支払者が含まれます。
地域別の展望
地域別に見ると、慢性疾患管理市場は北米、欧州、アジア太平洋およびLAMEAで分析されています。北米は、2021年に最も高い収益シェアを獲得し、慢性疾患管理市場の主要地域に浮上しました。これは、慢性疾患発生の増加、重要人物の存在、同地域のヘルスケアの改善によって説明されます。例えば、アメリカ人の10人のうち6人は、糖尿病、がん、心臓病、脳卒中など、少なくとも1つの慢性疾患を抱えており、これらはすべてこの国の医療費増加の主因であり、死亡や障害の主な原因となっています。
市場参加者がとる主な戦略は、製品の上市です。カーディナルマトリックスで提示された分析によると、慢性疾患管理市場では、ExlService Holdings, Inc.が主要な先駆者となっています。Health Catalyst, Inc.、AllScripts Healthcare Solutions, Inc.、Koninklijke Philips N.V.などの企業は、慢性疾患管理市場における主要な革新者の一人です。
Asia Pacific Asthma Market by Country, 2022 - 2028, USD Million 140
List of Figures
The Global Chronic Disease Management Market size is expected to reach $9.9 billion by 2028, rising at a market growth of 11.7% CAGR during the forecast period.
The treatment of chronic diseases is managed by an integrated care strategy that involves patient education, screenings, checkups, monitoring, and coordination of care. While lowering healthcare expenses, it can raise life quality. An ailment that lasts for a year or longer, necessitates continuing medical care, and/or restricts a person's everyday activities is often referred to as a chronic disease.
Heart disease, chronic respiratory diseases, high blood pressure, diabetes, stroke, asthma, and cancer are a few of the most prevalent chronic illnesses. Metabolic and behavioural risk factors are the two primary risks linked to chronic disease. In contrast to the metabolic risk factors, which include obesity, hyperglycemia, and high blood pressure, the behavioural risk factor includes the use of tobacco, inactivity, unhealthy eating, and problematic alcohol use.
The increase in the elderly population and the rise in the prevalence of numerous chronic diseases, such as cancer and others, are the main drivers of the chronic disease management market's expansion. For example, as per the NCBI, 43 percent of all diseases and 60 percent of deaths worldwide are caused by chronic conditions. Additionally, non-communicable diseases impact people of all ages, geographical areas, and nations, according to the WHO (NCDs).
Additionally, the growth of the Chronic Disease Management Market is driven by the rise in acceptance of chronic disease management as a result of the incorporation of IT solutions. To help people effectively manage their disease, a variety of initiatives have been developed by healthcare professionals, organizations, and payers. Such initiatives, in contrast to conventional patient education, place a stronger emphasis on problem-solving as well as social coping strategies in order to increase self-efficacy in the field of care management.
COVID-19 Impact Analysis
The market for managing chronic diseases continues to benefit from COVID-19's overall effects. The rising incidence of COVID-19 has increased the requirement for precise diagnostic and therapeutic tools in a number of nations. The ability of healthcare providers to easily connect solutions like patient management, EHR, and care management with healthcare payer solutions like claim management & payment management has shown to be quite beneficial in this regard. Additionally, the disease's quick global spread has led to lockdowns and other limitations, which has raised the demand for electronic data transfer & claim administration. In the upcoming years, it is anticipated that this will enhance the popularity of chronic disease management.
Market Growth Factors
Rising Cases Of Various Chronic Diseases
During the forecast period, the incidence of chronic diseases like diabetes, cancer, high blood pressure, and others would increase, boosting the market's growth rate. Given that older people are more likely to be obese and have diabetes, chronic diseases are a significant source of worry for them. Numerous patients undergoing chronic disease management face socioeconomic obstacles that make it challenging for them to routinely obtain and pay for healthcare treatments. If these patients lack the necessary funds, they may postpone or forego necessary therapy.
Growing Number Of Geriatric Population
Because life expectancy has increased over time, there are steadily more people in their 60s and older. As per the United Nations Database on World Population Ageing 2020, that there will be 1.5 billion elderly people worldwide by 2050, up from 727 million in 2020. The danger of developing chronic diseases is higher in the elderly, which drives up demand for the chronic disease management market. Since older population are more prone to various disease, particularly chronic ones, companies are majorly aiming at the introduction of advanced and improved solutions in the market.
Market Restraining Factors
Lack Of Proper Communication In Chronic Care Management
Delivering high-quality patient care depends on effective communication, which is also the cornerstone of provider-patient interactions. Providers are better able to offer the proper treatment when patients feel understood and heard. Long after the appointment has ended, the same patients are more willing to follow the recommended treatment strategies. The pandemic caused a profound change in patient expectations and behaviour.
Disease Type Outlook
Based on disease type, the chronic disease management market is segmented into Cardiovascular diseases, Diabetes, Cancer, Asthma, Chronic obstructive pulmonary disorders, and Others. The cancer segment witnessed a promising revenue share in the chronic disease management market in 2021. It is owing to the growing cases of various types of cancers among individuals. Typically, cancer types are called for the organs or tissues in which they first appear.
Type Outlook
On the basis of type, the chronic disease management market is bifurcated into Solutions and Services. The solutions segment acquired the highest revenue share in the chronic disease management market in 2021. The expansion of the chronic illness management system and the market are driven by the increased awareness of the utilization of cloud-based and on-premise solutions in healthcare.
End-User Outlook
By end-user, the chronic disease management market is classified into Healthcare Providers, Healthcare Payers and Others. Healthcare Payers segment procured a significant revenue share in the chronic disease management market in 2021. The market is expanding as a result of the increase in geriatric population and the incidence of chronic diseases. Organizations that determine service prices, process claims, collect payments, and pay provider claims include payers in the health care sector like Medicare, health plan providers, and Medicaid.
Regional Outlook
Region-wise, the chronic disease management market is analyzed across North America, Europe, Asia Pacific and LAMEA. North America emerged the leading region in the chronic disease management market with the highest revenue share in 2021. This is explained by an increase in chronic disease occurrences, the presence of important figures, and improvements in healthcare in the area. For instance, six out of ten Americans have at least one chronic illness, such as diabetes, cancer, heart disease, or a stroke, all of which are major contributors to this country's rising healthcare expenses and are major causes of mortality and disability.
The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; ExlService Holdings, Inc. is the major forerunner in the Chronic Disease Management Market. Companies such as Health Catalyst, Inc., AllScripts Healthcare Solutions, Inc. and Koninklijke Philips N.V. are some of the key innovators in Chronic Disease Management Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Infosys Limited, ExlService Holdings, Inc., Health Catalyst, Inc., AllScripts Healthcare Solutions, Inc., Koninklijke Philips N.V., Cognizant Technology Solutions Corporation, Casenet, LLC, Cedar Gate Technologies, Clinical Excellence, Inc., and Altruista Health, Inc.
Recent strategies deployed in Chronic Disease Management Market
Product Launches and Product Expansions:
May-2022: Koninklijke Philips introduced various new innovative additions to its prevailing healthcare solutions portfolio. These additions involve ultra-low contrast percutaneous coronary intervention (ULC-PCI), EchoNavigator 2.0, Dynamic Coronary Roadmap Software, iFR Co-registration, and IVUS Co-registration. ULC-PCI would assist interventionists to perform percutaneous coronary intervention with more confidence and clarity and at a much more decreased cost, EchoNavigator 4.0 would help in complicated heart disease treatment like heart valve repair or therapy.
Oct-2021: EXL launched a new omnichannel Patient Engagement Platform. This platform utilizes real-world patient information and powerful analytics to boost highly customized care management programs for health plans and self-insured employers.
Aug-2021: Casenet unveiled the TruCare care management solution integrated with clinical solutions for telehealth and remote patient monitoring (RPM) on the ZyterHealth platform. This integration of clinical data and care management data on the ZyterHealth platform would complement the objectives of value-based care programs by delivering providers and payers a more holistic view of both the medical issues and social problems affecting the patient's healthcare experience.
Nov-2020: Royal Philips launched a non-invasive Philips Ventilator BiPAP A40 EFL. The new device would assist pulmonologists to identify COPD patients with expiratory flow limitation (EFL) and treat them with targeted therapy to reduce symptoms and provide better comfort during sleep.
Sep-2020: Casenet introduced Zyter Home Health and Remote Patient Monitoring (RPM). This product is a complete, ready-to-implement solution that would expand healthcare and monitoring beyond the conventional environment, which would make it simpler for patients to participate in their own care and actively handle their conditions.
Jun-2020: Health Catalyst released comprehensive quality measures solution that would integrate its Data Operating System with the application of a scalable measure. This solution is developed to enhance provider quality measurement. To offer customers one comprehensive quality performance system by integrating comprehensive data from DOS with complete measures, visualizations, and workflows into one product.
Acquisitions and Mergers:
Dec-2021: Royal Philips acquired Vesper Medical, a medical technology company. This acquisition aimed to enable Philips to expand its diagnostic as well as therapeutic device portfolio with an improved venous stent portfolio to cure deep venous disease.
Nov-2021: Royal Philips took over Cardiologs, a France-based medical technology company. This acquisition aimed to complement Philips' prevailing portfolio of cardiac care solutions. This involves real-time patient monitoring, telehealth, therapeutic devices, and informatics for the hospital.
Oct-2021: Altruista Health acquired Wellframe, a digital health management company. This acquisition aimed to boost HealthEdge's portfolio of SaaS solutions over payer workflow operations and would mark HealthEdge's entry into member engagement.
Jan-2021: Cedar Gate Technologies took over Enli Health Intelligence, a provider of population health management technology solutions. This acquisition aimed to expand Cedar Gate's enterprise value-based care platform with the cohort, population, and patient management technologies, incorporating risk & quality measures, gaps in care identification, and patient outreach opportunities, for better results and sustainable financial outcomes.
Dec-2020: Philips took over BioTelemetry, a leading provider of remote cardiac diagnostics and monitoring. This acquisition aimed to strengthen Philips's offering of remote care products. Along with that, the acquisition would complement Philips' cardiac care portfolio, and its strategy to transform the delivery of care along the health continuum with combined solutions.
Partnerships, Collaborations and Agreements:
Aug-2022: Health Catalyst joined hands with LifePoint Health, an American company that provides healthcare services. This collaboration aimed to improve patient care and enhance results across the health system's network. In this collaboration, LifePoint Health would deploy Health Catalyst's suite of patient care solutions, involving a range of data collection and analytics platforms.
Mar-2022: Cognizant, the parent company of TriZetto Software Group collaborated with Microsoft, an American multinational technology corporation. This collaboration aimed to improve remote patient monitoring for improved medical care. Using data analytics, safe cloud technology, and interoperability products, this collaboration would deliver a unique, scalable solution that would focus to connect providers & patients and improve the timeliness, quality, and personalization of healthcare.
Approvals and Trials:
Mar-2022: Royal Philips got approval for the Philips Capsule Surveillance solution from the U.S. Food & Drug Administration (FDA). This FDA clearance of the new release of clinical surveillance solution would allow more integrated viewing options under EMR and HIT tools via the safe web-based customer interface.
Nov-2021: Royal Philips got 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new Liver Fat Quantification tools. This release of ultrasound systems EPIQ Elite and Affiniti would bring the cost and accessibility benefits of sonography to the diagnosis of early-stage liver disease.
Market Segments covered in the Report:
By Type
By End User
By Disease Type
By Geography
Companies Profiled
Unique Offerings from KBV Research